HomeAI · summaries
Storia in 3 fonti
Talquetamab Regimens Boost Survival in Multiple Myeloma
'Combinations represent additional options for early-line treatment,' researcher says
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
medpagetoday.com
Talquetamab Regimens Boost Survival in Multiple Myeloma
'Combinations represent additional options for early-line treatment,' researcher says
- ·
morningstar.com
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific…
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or…
